Effectiveness of Tobacco Cessation Interventions in Sweden

NCT ID: NCT04819152

Last Updated: 2022-08-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

8000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-09

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Smoking is still one of the most important risk factors causing morbidity and mortality in Sweden. Every year, 12,000 Swedish citizens die prematurely from smoking, and smoking is responsible for up to 60% of the inequity in health.

Though the smoking prevalence is relatively low in Sweden in an international context (8% and 10% for men and women respectively in 2016), specific vulnarable groups have a very high prevalence; e.g. about 80% in alcohol and drug abusers. Furthermore, Sweden has a unique high prevalence of snus users and in 2016 the daily use of tobacco was 25% for men and 14% for women. In addition, products such as cigarettes, snus, and e-cigettes are often mixed.

Despite the fact that about a thousand counsellors have been trained in manual-based person-centred tobacco cessation interventions in Sweden, the effectiveness of the interventions remains unknown, as a follow-up on effect of in-person interventions is not systematically collected in Sweden. Therefore, as of today it is not possible, on a national level, to compare the effectiveness of differences in these interventions, providers, or different groups of tobacco users including disadvantaged and vulnerable groups.

In this study the investigators will evaluate the effectiveness of already implemented in-person cessation interventions targeting smoking, use of snus and/or e-cigarettes, focusing on disadvantaged and vulnerable groups of tobacco users. Furthermore, important factors associated with a successful outcome after controlling for confounders will be identified (in relation to programme, patients and setting).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use Smoking Cigarette Use, Electronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exposed

Several studies will be performed based on this cohort. I each study the exposed group will be a group of tobacco users evaluatedin the relevant study. This could be a vulnarable group tobacco users such as: users without a job, with short or no education, without permanent housing, diagnosed with mental illness, diagnosed with chronic obstructive pulmonary disease (COPD), undergoing surgery, adolescents, elderly, migrants, or pregnant women.

Tobacco cessation intervention

Intervention Type BEHAVIORAL

Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden

Unexposed

In each study the unexposed group will consist of tobacco user from the study cohort without the condition examined in the relevant study.

Tobacco cessation intervention

Intervention Type BEHAVIORAL

Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tobacco cessation intervention

Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult tobacco users (of at least 18 years of age), including disadvantaged and vulnerable patients, receiving an in-person intervention (incl. online meetings) for tobacco cessation (smoking, snus and/or e-cigarettes) are eligible for inclusion in the project after giving informed consent.
* Both individual and group-based interventions can be included.

Exclusion Criteria

* Withdrawing consent.
* Reduced ability to give informed consent, due to inadequate language skills, dementia, and other conditions.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lund University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hanne Tonnesen

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hanne Tønnesen, DSc

Role: PRINCIPAL_INVESTIGATOR

Lund University, Clinical health promotion centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tobaksavvänjningen, Kirurgisk mott., CLV Växjö lasarett

Vaxjo, Kronoberg County, Sweden

Site Status RECRUITING

Capio Go

Malmo, Skåne County, Sweden

Site Status RECRUITING

Livsstilsmedicin Österåsen

Sollefteå, Västernorrland County, Sweden

Site Status RECRUITING

Tobakspreventiva enheten, USÖ

Örebro, , Sweden

Site Status RECRUITING

Tybble vårdcentral

Örebro, , Sweden

Site Status RECRUITING

Ekeby Hälsocenter

Uppsala, , Sweden

Site Status RECRUITING

Flogsta vårdcentral

Uppsala, , Sweden

Site Status RECRUITING

Tobakspreventiv mottagning Karlskoga

Karlskoga, Örebro County, Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mette Rasmussen, PhD

Role: CONTACT

+4538163850

Hanne Tønnesen, DSc

Role: CONTACT

+46724531481

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

M Uneklint

Role: primary

A Karlsson

Role: primary

A Mähler

Role: primary

A Stenius

Role: backup

M Larsson

Role: primary

M Larsson

Role: primary

K Brudin

Role: primary

I Granlund

Role: primary

M Randén

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Rasmussen M, Larsson M, Gilljam H, Adami J, Warjerstam S, Post A, Bjork-Eriksson T, Helgason AR, Tonnesen H. Effectiveness of tobacco cessation interventions for different groups of tobacco users in Sweden: a study protocol for a national prospective cohort study. BMJ Open. 2022 Jan 25;12(1):e053090. doi: 10.1136/bmjopen-2021-053090.

Reference Type BACKGROUND
PMID: 35078840 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Dnr: 2019-02221

Identifier Type: OTHER

Identifier Source: secondary_id

2017-01681

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

Rökstoppsprojektet

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation in Alcoholics
NCT00963482 COMPLETED NA
Effective Ads for Quitting Smoking
NCT06485479 COMPLETED NA